Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Tykerb, Tyverb, lapatinib
Also known as: GW572016
print preview
bookmark
share with colleague
General Information
Company
GlaxoSmithKline plc
Description
HER1 and HER2 receptor kinase inhibitor
Molecular Target
Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
;
Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of Action
Epidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor; Epidermal growth factor (EGF) receptor 1 (HER1) (ErbB1) inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy